Annual CFF
$76.68 M
-$59.71 M-43.78%
December 31, 2024
Summary
- As of March 12, 2025, TSHA annual cash flow from financing activities is $76.68 million, with the most recent change of -$59.71 million (-43.78%) on December 31, 2024.
- During the last 3 years, TSHA annual CFF has risen by +$37.60 million (+96.21%).
- TSHA annual CFF is now -73.65% below its all-time high of $291.06 million, reached on December 31, 2020.
Performance
TSHA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$357.00 K
-$6.95 M-105.41%
December 31, 2024
Summary
- As of March 12, 2025, TSHA quarterly cash flow from financing activities is -$357.00 thousand, with the most recent change of -$6.95 million (-105.41%) on December 31, 2024.
- Over the past year, TSHA quarterly CFF has stayed the same.
- TSHA quarterly CFF is now -100.13% below its all-time high of $274.18 million, reached on September 30, 2020.
Performance
TSHA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$76.68 M
+$3.89 M+5.35%
December 31, 2024
Summary
- As of March 12, 2025, TSHA TTM cash flow from financing activities is $76.68 million, with the most recent change of +$3.89 million (+5.35%) on December 31, 2024.
- Over the past year, TSHA TTM CFF has stayed the same.
- TSHA TTM CFF is now -73.79% below its all-time high of $292.55 million, reached on September 30, 2020.
Performance
TSHA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TSHA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.8% | 0.0% | 0.0% |
| 3 y3 years | +96.2% | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
TSHA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.8% | +96.2% | -100.3% | +91.6% | -62.9% | +284.0% |
| 5 y | 5-year | -73.7% | +96.2% | -100.1% | +91.6% | -73.8% | +325.4% |
| alltime | all time | -73.7% | +96.2% | -100.1% | +91.6% | -73.8% | +325.4% |
Taysha Gene Therapies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $76.68 M(-43.8%) | -$357.00 K(-105.4%) | $76.68 M(+5.3%) |
| Sep 2024 | - | $6.59 M(-90.6%) | $72.79 M(-64.8%) |
| Jun 2024 | - | $70.47 M(<-9900.0%) | $206.83 M(+51.3%) |
| Mar 2024 | - | -$22.00 K(-99.5%) | $136.74 M(+0.3%) |
| Dec 2023 | $136.39 M(+161.8%) | -$4.25 M(-103.0%) | $136.39 M(-25.0%) |
| Sep 2023 | - | $140.63 M(>+9900.0%) | $181.87 M(+342.1%) |
| Jun 2023 | - | $377.00 K(-201.9%) | $41.14 M(-20.6%) |
| Mar 2023 | - | -$370.00 K(-100.9%) | $51.83 M(-0.5%) |
| Dec 2022 | $52.10 M | $41.23 M(<-9900.0%) | $52.10 M(+160.9%) |
| Sep 2022 | - | -$103.00 K(-100.9%) | $19.97 M(-60.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $11.07 M(<-9900.0%) | $50.05 M(+28.4%) |
| Mar 2022 | - | -$107.00 K(-101.2%) | $38.98 M(-0.3%) |
| Dec 2021 | $39.08 M(-86.6%) | $9.11 M(-69.6%) | $39.08 M(+37.2%) |
| Sep 2021 | - | $29.98 M(>+9900.0%) | $28.50 M(-89.6%) |
| Jun 2021 | - | $0.00(0.0%) | $272.70 M(-0.1%) |
| Mar 2021 | - | $0.00(-100.0%) | $273.04 M(-6.2%) |
| Dec 2020 | $291.06 M | - | - |
| Dec 2020 | - | -$1.48 M(-100.5%) | $291.06 M(-0.5%) |
| Sep 2020 | - | $274.18 M(>+9900.0%) | $292.55 M(+1493.0%) |
| Jun 2020 | - | $338.00 K(-98.1%) | $18.36 M(+1.9%) |
| Mar 2020 | - | $18.03 M | $18.03 M |
FAQ
- What is Taysha Gene Therapies annual cash flow from financing activities?
- What is the all time high annual CFF for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual CFF year-on-year change?
- What is Taysha Gene Therapies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly CFF year-on-year change?
- What is Taysha Gene Therapies TTM cash flow from financing activities?
- What is the all time high TTM CFF for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM CFF year-on-year change?
What is Taysha Gene Therapies annual cash flow from financing activities?
The current annual CFF of TSHA is $76.68 M
What is the all time high annual CFF for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual cash flow from financing activities is $291.06 M
What is Taysha Gene Therapies annual CFF year-on-year change?
Over the past year, TSHA annual cash flow from financing activities has changed by -$59.71 M (-43.78%)
What is Taysha Gene Therapies quarterly cash flow from financing activities?
The current quarterly CFF of TSHA is -$357.00 K
What is the all time high quarterly CFF for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly cash flow from financing activities is $274.18 M
What is Taysha Gene Therapies quarterly CFF year-on-year change?
Over the past year, TSHA quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Taysha Gene Therapies TTM cash flow from financing activities?
The current TTM CFF of TSHA is $76.68 M
What is the all time high TTM CFF for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM cash flow from financing activities is $292.55 M
What is Taysha Gene Therapies TTM CFF year-on-year change?
Over the past year, TSHA TTM cash flow from financing activities has changed by $0.00 (0.00%)